BioCentury
ARTICLE | Clinical News

MSC_Apceth: Phase I/II started

September 5, 2011 7:00 AM UTC

Apceth began an open-label, German Phase I/II trial to compare percutaneous transluminal angioplasty followed by infusion of MSC_Apceth vs. percutaneous transluminal angioplasty alone in 30 patients. ...